sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Multiple Sclerosis: Epidemiology Forecasting Intelligence

Multiple Sclerosis: Epidemiology Forecasting Intelligence

Home / Categories / Healthcare
Multiple Sclerosis: Epidemiology Forecasting Intelligence
Multiple Sclerosis: Epidemiology Forecasting Intelligence
Report Code
RO1/114/1035

Publish Date
01/Mar/2019

Pages
50-70
PRICE
$ 2500/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 6000/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1. Report Introduction
2. Multiple Sclerosis Epidemiology Overview at a Glance
3. Market Share Distribution of Multiple Sclerosis
4. Disease Background and Overview: Multiple Sclerosis
4.1. Introduction
4.2. Signs and Symptoms
4.3. Etiology
4.4. Risk Factors
4.5. Pathophysiology
4.6. Diagnostic Landscape
4.6.1. Diagnostic Practices
4.6.2. Diagnostic Criteria
4.6.3. Diagnostic Recommendations
4.7. Treatment Landscape
4.7.1. Current Treatment Practices
4.7.2. Treatment Algorithm
4.7.3. Treatment Recommendations
5. Multiple Sclerosis Epidemiology
5.1. Key Findings
5.2. Assumptions & Rationale
5.3. 7MM Epidemiology
6. Epidemiology of Multiple Sclerosis by Countries
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent/Incident Cases of Multiple Sclerosis
7.3. Sub-Type Specific cases of Multiple Sclerosis*
7.4. Sex- Specific Cases of Multiple Sclerosis*
7.5. Diagnosed Cases of Multiple Sclerosis
7.6. Treated Cases of Multiple Sclerosis
8. EU5
8.1. Germany
8.1.1. Assumptions and Rationale
8.1.2. Prevalent/Incident Cases of Multiple Sclerosis
8.1.3. Sub-Type Specific cases of Multiple Sclerosis*
8.1.4. Sex- Specific Cases of Multiple Sclerosis*
8.1.5. Diagnosed Cases of Multiple Sclerosis
8.1.6. Treated Cases of Multiple Sclerosis
8.2. France
8.2.1. Assumptions and Rationale
8.2.2. Prevalent/Incident Cases of Multiple Sclerosis
8.2.3. Sub-Type Specific cases of Multiple Sclerosis*
8.2.4. Sex- Specific Cases of Multiple Sclerosis*
8.2.5. Diagnosed Cases of Multiple Sclerosis
8.2.6. Treated Cases of Multiple Sclerosis
8.3. United Kingdom
8.3.1. Assumptions and Rationale
8.3.2. Prevalent/Incident Cases of Multiple Sclerosis
8.3.3. Sub-Type Specific cases of Multiple Sclerosis*
8.3.4. Sex- Specific Cases of Multiple Sclerosis*
8.3.5. Diagnosed Cases of Multiple Sclerosis
8.3.6. Treated Cases of Multiple Sclerosis
8.4. Spain
8.4.1. Assumptions and Rationale
8.4.2. Prevalent/Incident Cases of Multiple Sclerosis
8.4.3. Sub-Type Specific cases of Multiple Sclerosis*
8.4.4. Sex- Specific Cases of Multiple Sclerosis*
8.4.5. Diagnosed Cases of Multiple Sclerosis
8.4.6. Treated Cases of Multiple Sclerosis
8.5. Italy
8.5.1. Assumptions and Rationale
8.5.2. Prevalent/Incident Cases of Multiple Sclerosis
8.5.3. Sub-Type Specific cases of Multiple Sclerosis*
8.5.4. Sex- Specific Cases of Multiple Sclerosis*
8.5.5. Diagnosed Cases of Multiple Sclerosis
8.5.6. Treated Cases of Multiple Sclerosis
9. Japan
9.1. Assumptions and Rationale
9.2. Prevalent/Incident Cases of Multiple Sclerosis
9.3. Sub-Type Specific cases of Multiple Sclerosis*
9.4. Sex- Specific Cases of Multiple Sclerosis*
9.5. Diagnosed Cases of Multiple Sclerosis
9.6. Treated Cases of Multiple Sclerosis
10. Unmet Needs
Appendix
Report Methodology
Sources Used
Disclaimer
About CmaxInsight
*Indication Specific

Note: Certain sections of the table of contents would vary according to the availability of information.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com